ConductScience.org, home

Paper835580

Lupus nephritis. Clinical course as related to morphologic forms and their transitions.

Baldwin DS and 3 others. Am J Med, 1977. Cited by 340 papers, by iCite.

Cite this record

ConductScience Library. Lupus nephritis. Clinical course as related to morphologic forms and their transitions. Papers, record 835580. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/835580

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lupus nephritis. Clinical course as related to morphologic forms and their transitions.
PubMed
Journal
Am J Med
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
340
iCite
Relative citation ratio, by iCite
12.4
iCite
Revised in PubMed
2019-06-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baldwin DSD S
2Gluck MCM C
3Lowenstein JJ
4Gallo GRG R

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lupus Erythematosus, SystemicMajor topic
NephritisMajor topic
Adolescent
Adult
Antineoplastic Agents
Child
Female
Glomerulosclerosis, Focal Segmental
Humans
Male
Middle Aged
Prednisone
Vascular Diseases

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00001212Drug Therapy in Lupus NephropathyBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 340 citations.

PMIDTitleJournalYearIn PapersSource
42367668Interdisciplinary Clinical Practice Guidelines for patient-centred management of juvenile-onset systemic lupus erythematosus.EULAR Rheumatol Open2025https://conductscience.org/library/papers/42367668PubMed
41082628Current treatment of lupus nephritis: an overview of the new guidelines.J Bras Nefrol2025https://conductscience.org/library/papers/41082628PubMed
40308411Epistaxis and Hypertensive Emergency as the First Signs of Lupus Nephritis.Cureus2025https://conductscience.org/library/papers/40308411PubMed
40126656Silent lupus nephritis: a pediatric center experience of baseline kidney biopsies and review of the published evidence.Pediatr Nephrol2025https://conductscience.org/library/papers/40126656PubMed
37732045Renal involvement in systemic lupus erythematosus: additional histopathological lesions.Arch Med Sci2023https://conductscience.org/library/papers/37732045PubMed
34549340Long-term renal outcomes of mesangial proliferative lupus nephritis in Chinese patients.Clin Rheumatol2022https://conductscience.org/library/papers/34549340PubMed
29866798The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study.J Am Soc Nephrol2018https://conductscience.org/library/papers/29866798PubMed
29692991Rapid and Complete Remission of Class IV Lupus Nephritis with Massive Wire Loop Lesions.Case Rep Nephrol Dial2018https://conductscience.org/library/papers/29692991PubMed
28682905Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study.Medicine (Baltimore)2017https://conductscience.org/library/papers/28682905PubMed
28509272An unusual association between focal segmental sclerosis and lupus nephritis: a distinct concept from lupus podocytopathy?CEN Case Rep2015https://conductscience.org/library/papers/28509272PubMed
28384208Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study.PLoS One2017https://conductscience.org/library/papers/28384208PubMed
28086993Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV.Arthritis Res Ther2017https://conductscience.org/library/papers/28086993PubMed
27517432Systemic lupus erythematosus: Renal involvement and prognosis.Ir J Med Sci1979https://conductscience.org/library/papers/27517432PubMed
27304068Comparison of Outcomes between Individuals with Pure and Mixed Lupus Nephritis: A Retrospective Study.PLoS One2016https://conductscience.org/library/papers/27304068PubMed
27152693Long-term Outcome of Lupus Nephritis Class II in Argentine Patients: An Open Retrospective Analysis.J Clin Rheumatol2016https://conductscience.org/library/papers/27152693PubMed
26983707Clinical-Morphological Features and Outcomes of Lupus Podocytopathy.Clin J Am Soc Nephrol2016https://conductscience.org/library/papers/26983707PubMed
26722454Association of miRNA-145 expression in vascular smooth muscle cells with vascular damages in patients with lupus nephritis.Int J Clin Exp Pathol2015https://conductscience.org/library/papers/26722454PubMed
26152271The Revisited Classification of GN in SLE at 10 Years: Time to Re-Evaluate Histopathologic Lesions.J Am Soc Nephrol2015https://conductscience.org/library/papers/26152271PubMed
20556453Analysis of clinical manifestations and pathology of lupus nephritis: a retrospective review of 82 cases.Clin Rheumatol2010https://conductscience.org/library/papers/20556453PubMed
20453520Rapidly deteriorating kidney function in a young man previously diagnosed with membranous nephropathy.Nephron Clin Pract2010https://conductscience.org/library/papers/20453520PubMed

See all 44 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/835580

GET https://conductscience.org/api/papers/v1/835580/cited_by?page=2